Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trophoblasts | 6 | 2022 | 119 | 1.630 |
Why?
|
| Prenatal Diagnosis | 3 | 2025 | 632 | 1.340 |
Why?
|
| Embryonic Stem Cells | 6 | 2017 | 178 | 1.140 |
Why?
|
| Stillbirth | 1 | 2025 | 103 | 0.880 |
Why?
|
| Congenital Abnormalities | 1 | 2025 | 298 | 0.740 |
Why?
|
| Chromosome Disorders | 2 | 2023 | 316 | 0.730 |
Why?
|
| DNA Copy Number Variations | 4 | 2025 | 1034 | 0.690 |
Why?
|
| Genetic Testing | 4 | 2024 | 1099 | 0.660 |
Why?
|
| Histones | 4 | 2016 | 573 | 0.600 |
Why?
|
| Chromosome Aberrations | 2 | 2018 | 628 | 0.590 |
Why?
|
| Genetic Markers | 1 | 2019 | 635 | 0.560 |
Why?
|
| Placenta | 3 | 2022 | 536 | 0.540 |
Why?
|
| Gene Duplication | 1 | 2018 | 372 | 0.520 |
Why?
|
| Gene Deletion | 1 | 2018 | 811 | 0.480 |
Why?
|
| Cell Differentiation | 4 | 2014 | 2045 | 0.430 |
Why?
|
| Pregnancy | 10 | 2025 | 7570 | 0.410 |
Why?
|
| Single-Cell Analysis | 3 | 2021 | 358 | 0.380 |
Why?
|
| Genetic Loci | 1 | 2013 | 367 | 0.370 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1332 | 0.340 |
Why?
|
| Proteomics | 4 | 2017 | 599 | 0.310 |
Why?
|
| Cell Separation | 2 | 2020 | 234 | 0.300 |
Why?
|
| Vulnerable Populations | 2 | 2024 | 148 | 0.240 |
Why?
|
| CADASIL | 1 | 2024 | 7 | 0.230 |
Why?
|
| Glutarates | 1 | 2024 | 38 | 0.230 |
Why?
|
| Humans | 32 | 2025 | 134156 | 0.230 |
Why?
|
| Paraganglioma | 1 | 2024 | 25 | 0.220 |
Why?
|
| Mediator Complex | 1 | 2024 | 57 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2024 | 59 | 0.220 |
Why?
|
| Brain Abscess | 1 | 2024 | 54 | 0.210 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2024 | 169 | 0.210 |
Why?
|
| Hemiplegia | 1 | 2023 | 43 | 0.210 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2024 | 121 | 0.210 |
Why?
|
| Proteolysis | 2 | 2014 | 199 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 2 | 2022 | 1837 | 0.210 |
Why?
|
| Cell Line | 5 | 2016 | 2864 | 0.210 |
Why?
|
| Female | 16 | 2025 | 71928 | 0.200 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2024 | 83 | 0.200 |
Why?
|
| Retinitis Pigmentosa | 1 | 2024 | 96 | 0.200 |
Why?
|
| Neutropenia | 1 | 2024 | 205 | 0.200 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2024 | 160 | 0.200 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 159 | 0.190 |
Why?
|
| Exons | 1 | 2025 | 839 | 0.190 |
Why?
|
| Thrombocytopenia | 1 | 2023 | 237 | 0.180 |
Why?
|
| Fetus | 2 | 2023 | 601 | 0.180 |
Why?
|
| Metabolomics | 1 | 2024 | 470 | 0.170 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2024 | 464 | 0.170 |
Why?
|
| Chemical Fractionation | 2 | 2017 | 14 | 0.170 |
Why?
|
| Rare Diseases | 1 | 2023 | 209 | 0.170 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2018 | 434 | 0.170 |
Why?
|
| Intellectual Disability | 2 | 2024 | 1091 | 0.170 |
Why?
|
| Adult | 6 | 2025 | 31945 | 0.160 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 227 | 0.160 |
Why?
|
| Mutation, Missense | 1 | 2024 | 947 | 0.160 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2024 | 422 | 0.160 |
Why?
|
| Repressor Proteins | 1 | 2024 | 874 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 426 | 0.150 |
Why?
|
| Karyotype | 1 | 2018 | 34 | 0.150 |
Why?
|
| Mass Spectrometry | 2 | 2017 | 370 | 0.150 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 143 | 0.150 |
Why?
|
| Proteome | 2 | 2017 | 281 | 0.140 |
Why?
|
| Peptide Library | 1 | 2017 | 61 | 0.140 |
Why?
|
| Pregnancy Complications | 1 | 2022 | 553 | 0.130 |
Why?
|
| Young Adult | 3 | 2024 | 9944 | 0.130 |
Why?
|
| Maternal Serum Screening Tests | 1 | 2016 | 3 | 0.130 |
Why?
|
| Tretinoin | 2 | 2014 | 118 | 0.130 |
Why?
|
| Physicians | 1 | 2023 | 639 | 0.130 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2016 | 23 | 0.130 |
Why?
|
| Gestational Age | 1 | 2020 | 1229 | 0.120 |
Why?
|
| Culture Media | 1 | 2016 | 184 | 0.120 |
Why?
|
| Retrospective Studies | 5 | 2025 | 17540 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 384 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 964 | 0.120 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 666 | 0.120 |
Why?
|
| Male | 10 | 2024 | 66127 | 0.120 |
Why?
|
| DNA | 1 | 2021 | 1682 | 0.120 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 580 | 0.110 |
Why?
|
| Exome | 3 | 2024 | 1087 | 0.110 |
Why?
|
| Leukocyte Elastase | 1 | 2014 | 22 | 0.110 |
Why?
|
| Arginine | 1 | 2016 | 351 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2020 | 1719 | 0.110 |
Why?
|
| beta 2-Microglobulin | 1 | 2013 | 34 | 0.110 |
Why?
|
| Endopeptidases | 1 | 2014 | 119 | 0.110 |
Why?
|
| Activins | 1 | 2013 | 74 | 0.100 |
Why?
|
| Alu Elements | 1 | 2013 | 67 | 0.100 |
Why?
|
| Ribosomal Proteins | 1 | 2013 | 76 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 337 | 0.100 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 177 | 0.100 |
Why?
|
| Reference Standards | 1 | 2013 | 247 | 0.100 |
Why?
|
| Genes | 1 | 2013 | 450 | 0.100 |
Why?
|
| Software | 1 | 2017 | 735 | 0.100 |
Why?
|
| Genotype | 1 | 2018 | 2814 | 0.100 |
Why?
|
| Germ Cells | 1 | 2013 | 204 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1923 | 0.080 |
Why?
|
| Infant | 4 | 2024 | 13240 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 311 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2024 | 8623 | 0.060 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2016 | 44 | 0.060 |
Why?
|
| Receptor, Notch3 | 1 | 2024 | 12 | 0.060 |
Why?
|
| Anus, Imperforate | 1 | 2024 | 20 | 0.060 |
Why?
|
| Mice | 4 | 2014 | 19055 | 0.060 |
Why?
|
| Blepharophimosis | 1 | 2024 | 26 | 0.060 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2024 | 20 | 0.060 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2024 | 44 | 0.060 |
Why?
|
| Phenotype | 2 | 2024 | 4598 | 0.060 |
Why?
|
| Facies | 1 | 2024 | 156 | 0.050 |
Why?
|
| Cell Culture Techniques | 2 | 2016 | 294 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2024 | 79 | 0.050 |
Why?
|
| Genes, X-Linked | 1 | 2024 | 64 | 0.050 |
Why?
|
| Blepharoptosis | 1 | 2024 | 64 | 0.050 |
Why?
|
| Constipation | 1 | 2024 | 126 | 0.050 |
Why?
|
| Muscle Hypotonia | 1 | 2024 | 200 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2023 | 54 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2024 | 162 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2023 | 167 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 94 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2023 | 103 | 0.050 |
Why?
|
| Cleft Palate | 1 | 2024 | 155 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2024 | 234 | 0.050 |
Why?
|
| Animals | 5 | 2014 | 36557 | 0.050 |
Why?
|
| Laboratories | 1 | 2023 | 89 | 0.050 |
Why?
|
| Heterozygote | 1 | 2024 | 728 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 260 | 0.050 |
Why?
|
| Syndrome | 1 | 2024 | 1167 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2025 | 1071 | 0.050 |
Why?
|
| Cells | 1 | 2021 | 25 | 0.040 |
Why?
|
| Pedigree | 1 | 2024 | 1728 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 625 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2024 | 868 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2023 | 359 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 3043 | 0.040 |
Why?
|
| Mutation | 2 | 2024 | 6338 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 297 | 0.040 |
Why?
|
| Biomarkers | 2 | 2022 | 3434 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2024 | 14884 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2024 | 979 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 649 | 0.040 |
Why?
|
| Genome, Human | 1 | 2025 | 1351 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 29399 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2016 | 106 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 363 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 241 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 153 | 0.030 |
Why?
|
| Workflow | 1 | 2016 | 135 | 0.030 |
Why?
|
| Genomics | 1 | 2024 | 1681 | 0.030 |
Why?
|
| Adolescent | 2 | 2024 | 20624 | 0.030 |
Why?
|
| Vitronectin | 1 | 2014 | 5 | 0.030 |
Why?
|
| Feeder Cells | 1 | 2014 | 9 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2014 | 69 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 294 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 127 | 0.030 |
Why?
|
| Embryoid Bodies | 1 | 2013 | 6 | 0.030 |
Why?
|
| GATA6 Transcription Factor | 1 | 2013 | 12 | 0.030 |
Why?
|
| Endoderm | 1 | 2013 | 24 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2013 | 39 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 827 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 313 | 0.030 |
Why?
|
| Child | 2 | 2024 | 25890 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 402 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3506 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2013 | 79 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 1884 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6601 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 837 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 551 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 488 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 2795 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2014 | 928 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1539 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3980 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 21775 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 4934 | 0.010 |
Why?
|